Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Skinner

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biochemistry|November 17, 2007
Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chainsLawreen H Connors, Yan Jiang, Marianna Budnik, et al.
The Journal of Biological Chemistry|September 28, 2010
Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrilsRuiyi Ren, Zhenning Hong, Haiyan Gong, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
American Heart Journal|September 29, 2009
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosisLawreen H Connors, Tatiana Prokaeva, Amareth Lim, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Biophysical Journal|March 29, 2005
Thermodynamic stability of a kappaI immunoglobulin light chain: relevance to multiple myelomaConnie M Chung, Jenny D Chiu, Lawreen H Connors, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
American Heart Journal|August 11, 2012
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)Frederick L Ruberg, Mathew S Maurer, Daniel P Judge, et al.
Clinical Lymphoma|April 4, 2003
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosisDavid C Seldin, Elie B Choufani, Laura M Dember, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biochemistry|November 17, 2007
Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chainsLawreen H Connors, Yan Jiang, Marianna Budnik, et al.
The Journal of Biological Chemistry|September 28, 2010
Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrilsRuiyi Ren, Zhenning Hong, Haiyan Gong, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
American Heart Journal|September 29, 2009
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosisLawreen H Connors, Tatiana Prokaeva, Amareth Lim, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Biophysical Journal|March 29, 2005
Thermodynamic stability of a kappaI immunoglobulin light chain: relevance to multiple myelomaConnie M Chung, Jenny D Chiu, Lawreen H Connors, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
American Heart Journal|August 11, 2012
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)Frederick L Ruberg, Mathew S Maurer, Daniel P Judge, et al.
Clinical Lymphoma|April 4, 2003
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosisDavid C Seldin, Elie B Choufani, Laura M Dember, et al.
Pageof 6